Uncover key drivers, emerging technologies, and competitive movements shaping the cell and gene therapy market from 2026–2035 with trusted insights from The Business Research Company
What level of CAGR-driven expansion is anticipated in the Cell and Gene Therapy Market between 2026 and 2030?
The cell and gene therapy market size has experienced rapid expansion in recent years. This market is projected to expand from $21.33 billion in 2025 to $26.21 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 22.9%. Factors contributing to its historical growth include the limited availability of cell and gene therapies, a reliance on conventional treatment methods, the high cost of initial-generation therapies, an increasing prevalence of oncology and neurological conditions, and a scarcity of specialized treatment facilities.
The cell and gene therapy market size is projected to experience substantial growth over the next few years, reaching $60.58 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.3%. This expansion during the forecast period is fueled by advancements in car-t and genome editing therapies, the broadening of clinical trials and research programs, a wider embrace of personalized medicine, increased government backing and funding for rare disease treatments, and the incorporation of digital platforms for therapy oversight and patient management. Significant trends anticipated during this period encompass the growing utilization of car-t and stem cell therapies, augmented investment in gene therapy for oncology and rare diseases, a surge in personalized and targeted cell-based treatments, the expansion of hospital and ambulatory surgical centers providing advanced therapies, and the integration of genome editing and viral vector-based technologies into clinical practice.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp
What Drivers Are Affecting Demand-Supply Dynamics In The Cell and Gene Therapy Market?
The future expansion of the cell and gene therapy market is anticipated to be propelled by a rising number of ongoing clinical trials. These research studies are conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Clinical trials play a crucial role in the development and advancement of cell and gene therapy, offering a secure and regulated setting to test new therapies and gather data on their safety and efficacy. For instance, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the number of pharmaceutical industry trials initiated in the UK increased for the second consecutive year, growing from 411 in 2022 to 426 in 2023. Therefore, the increasing number of ongoing clinical trials is actively driving the growth of the cell and gene therapy market.
How Is The Cell and Gene Therapy Market Organized Into Various Segments?
The cell and gene therapy market covered in this report is segmented –
1) By Product: Cell Therapy, Gene Therapy
2) By Application: Oncology, Neurological Disorders, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users
Subsegments:
1) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, CAR-T Cell Therapy
2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Genome Editing Technologies, Antisense Oligonucleotide Therapy
What Industry Trends Are Transforming The Cell and Gene Therapy Market?
Major companies active in the cell and gene therapy market are increasingly focusing on introducing agnostic systems to gain a competitive advantage. Agnostic systems are defined as those that seamlessly integrate with various cell and gene therapy (CGT) software platforms, as well as biopharmaceutical or provider-facing platforms. For instance, in April 2023, AmerisourceBergen, a US-based healthcare company, unveiled the Cell and Gene Therapy Integration Hub. This new platform-agnostic system aims to enhance connectivity throughout the cell and gene therapy (CGT) treatment journey, facilitating an improved patient and provider experience. The hub operates using the company’s customer relationship management system and is engineered to expedite the benefits investigation process, offer a real-time perspective on therapy development and transportation status, and assist in coordinating patient support.
Who Are The Core Companies Influencing Trends In The Cell and Gene Therapy Market?
Major companies operating in the cell and gene therapy market are Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., ArrowHead Pharmaceuticals Inc., Spark Therapeutics, Bluebird Bio Inc., RegenexBio, Mesoblast Limited, Stempeutics Research Pvt. Ltd., EdiGene Inc., Takara Bio, Oxford Biomedica plc, Merck, GenScript, Cellular Biomedicine Group, inStem, Bristol-Myers Squibb, Amgen, Pfizer, Kite Pharma, Freeline Therapeutics, PsiOxus Therapeutics, Herantis Pharma Plc, AstraZeneca
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report
Which Regions Are Projected To Dominate The Cell and Gene Therapy Market In The Coming Years?
North America was the largest region in the cell and gene therapy market in 2025. The regions covered in the cell and gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Cell and Gene Therapy Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3472&type=smp
Browse Through More Reports Similar to the Global Cell and Gene Therapy Market 2026, By The Business Research Company
Cancer Biologics Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Nucleic Acid Based Gene Therapy Market Report 2026
Genes Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model